Dr. Eugene Braunwald and Dr. C. Michael Gibson Discuss: Prospective Arni Versus Ace Inhibitor Trial To Determine Superiority In Reducing Heart Failure Events After Myocardial Infarction (paradise-mi) May 15, 2021 Disclosures: TBD
Dr. Rupert Bauersachs and Dr. C. Michael Gibson Discuss: Reductions In Total Ischemic Events With Rivaroxaban In Patients With Symptomatic Pad After Revascularization: The VOYAGER PAD Trial May 15, 2021 Disclosures: TBD
Dr. John Teerlink and Dr. C. Michael Gibson Discuss: Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: The Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in Heart Failure (GALACTIC-HF) Trial November 17, 2020 Disclosures: TBA
Dr. Deepak Bhatt and Dr. C. Michael Gibson Discuss: Divergent Results in the STRENGTH and REDUCE-IT trials November 16, 2020 Disclosures: TBA
